These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3003124)

  • 1. A comparison of the platelet-derived growth factor-dependent tyrosine kinase activity in sparse and confluent fibroblasts.
    Kazlauskas A; DiCorleto PE
    J Cell Physiol; 1986 Feb; 126(2):225-36. PubMed ID: 3003124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta 1 inhibitory effect of platelet-derived growth factor-induced signal transduction on human bone marrow fibroblasts: possible involvement of protein phosphatases.
    Fontenay M; Bryckaert M; Tobelem G
    J Cell Physiol; 1992 Sep; 152(3):507-19. PubMed ID: 1324246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the phosphorylation events in membranes from proliferating vs. quiescent endothelial cells.
    Kazlauskas A; DiCorleto PE
    J Cell Physiol; 1987 Feb; 130(2):228-44. PubMed ID: 3818801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a high-molecular-weight protein immunoprecipitated by platelet-derived growth factor antisera.
    Graves DT; Antoniades HN
    J Cell Physiol; 1988 Nov; 137(2):263-71. PubMed ID: 2461374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication.
    Pelletier DB; Boynton AL
    J Cell Physiol; 1994 Mar; 158(3):427-34. PubMed ID: 8126067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alpha-receptors.
    Paulsson Y; Karlsson C; Heldin CH; Westermark B
    J Cell Physiol; 1993 Oct; 157(1):97-103. PubMed ID: 8408247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
    Keating MT; Escobedo JA; Fantl WJ; Williams LT
    Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
    Benito M; Lorenzo M
    Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphotyrosine phosphatases reveals candidate substrates of the PDGF receptor kinase.
    Zippel R; Morello L; Brambilla R; Comoglio PM; Alberghina L; Sturani E
    Eur J Cell Biol; 1989 Dec; 50(2):428-34. PubMed ID: 2560717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
    Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
    J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PDGF receptor domain essential for mitogenesis but not for many other responses to PDGF.
    Escobedo JA; Williams LT
    Nature; 1988 Sep; 335(6185):85-7. PubMed ID: 2842689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 modulates phosphorylation of proteins in human osteoblastic cells.
    Kang YM; Yeh YL; Graves DT
    J Bone Miner Res; 1995 Jan; 10(1):96-105. PubMed ID: 7747636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF induction of tyrosine phosphorylation of GTPase activating protein.
    Molloy CJ; Bottaro DP; Fleming TP; Marshall MS; Gibbs JB; Aaronson SA
    Nature; 1989 Dec; 342(6250):711-4. PubMed ID: 2480526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication.
    Womer RB; Frick K; Mitchell CD; Ross AH; Bishayee S; Scher CD
    J Cell Physiol; 1987 Jul; 132(1):65-72. PubMed ID: 2439522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.
    Huang JS; Nishimura J; Huang SS; Deuel TF
    J Cell Biochem; 1984; 26(4):205-20. PubMed ID: 6099364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
    Sachsenmaier C; Sadowski HB; Cooper JA
    Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.